Chastened Innate Returns Lumoxiti Rights To AZ
Struggled To Commercialize Hairy Cell Leukemia Drug
The French firm gave back the rights to Lumoxiti on the same day the drug got a thumbs up from the CHMP after struggling to market the rare leukemia drug in the US.
